Literature DB >> 18024874

Initiation and discontinuation of complementary therapy among cancer patients.

Sung-Gyeong Kim1, Eun-Cheol Park, Jae-Hyun Park, Myung-Il Hahm, Jin-Hwa Lim, Kui-Son Choi.   

Abstract

PURPOSE: To identify the initiation or discontinuation of complementary therapy (CT) and determine the impact of sociodemographic and clinical factors on CT use among cancer patients. PATIENTS AND METHODS: Eligible patients were age 20 or older; newly diagnosed with stomach, liver, or colorectal cancer; and started their initial treatment at the National Cancer Center, Korea, between April 1, 2001, and April 30, 2003. In total, 541 cancer patients were surveyed in face-to-face interviews at baseline, and telephone follow-up interviews were performed every 3 months for 3 years.
RESULTS: A total of 281 patients commenced CT after diagnosis; 164 patients stopped using CT during the follow-up period. The overall cumulative probability of starting CT at 1, 2, and 3 years was 50%, 54%, and 55%, respectively. In a Cox multivariate analysis, stomach and liver cancer were associated with an increased probability of initiating CT compared with colorectal cancer. Patients who were classified as stage I, II, or III at diagnosis were associated with a decreased probability of discontinuing CT compared with stage IV.
CONCLUSION: Most cancer patients started to use CT during the initial treatment period. Thus, physicians should communicate with cancer patients about CT at this phase. In particular, more attention should be paid to women and individuals with higher household incomes because these groups are more likely to start CT.

Entities:  

Mesh:

Year:  2007        PMID: 18024874     DOI: 10.1200/JCO.2007.11.9651

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  6 in total

1.  Use of non-conventional medicine two years after cancer diagnosis in France: evidence from the VICAN survey.

Authors:  Aline Sarradon-Eck; Anne-Déborah Bouhnik; Dominique Rey; Marc-Karim Bendiane; Laetitia Huiart; Patrick Peretti-Watel
Journal:  J Cancer Surviv       Date:  2017-02-01       Impact factor: 4.442

Review 2.  The effectiveness and safety of moxibustion for treating cancer-related fatigue: a systematic review and meta-analyses.

Authors:  Seunghoon Lee; Ui Min Jerng; Yan Liu; Jung Won Kang; Dongwoo Nam; Jae-dong Lee
Journal:  Support Care Cancer       Date:  2014-03-08       Impact factor: 3.603

3.  Using a positive self-talk intervention to enhance coping skills in breast cancer survivors: lessons from a community-based group delivery model.

Authors:  R Hamilton; B Miedema; L Macintyre; J Easley
Journal:  Curr Oncol       Date:  2011-04       Impact factor: 3.677

4.  Complementary and alternative therapies among very long-term breast cancer survivors.

Authors:  C L Carpenter; P A Ganz; L Bernstein
Journal:  Breast Cancer Res Treat       Date:  2008-08-20       Impact factor: 4.872

5.  Kidney dysfunction and cerebral microbleeds in neurologically healthy adults.

Authors:  Sang Hyuck Kim; Dong Wook Shin; Jae Moon Yun; Ji Eun Lee; Jae-Sung Lim; Be Long Cho; Hyung-Min Kwon; Jin-Ho Park
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

6.  Moxibustion for cancer-related fatigue: study protocol for a randomized controlled trial.

Authors:  Mikyung Kim; Jung-Eun Kim; Hye-Yoon Lee; Ae-Ran Kim; Hyo-Ju Park; O-Jin Kwon; Eun-Jung Kim; Yeon-Cheol Park; Byung-Kwan Seo; Jung Hyo Cho; Joo-Hee Kim
Journal:  BMC Complement Altern Med       Date:  2017-07-05       Impact factor: 3.659

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.